Ameparomo Capsules 250 mg Drug Use Investigation
NCT02680665 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120
Last updated 2020-12-09
Summary
This Study is intended to evaluate the safety and effectiveness of Ameparomo Capsules 250 mg under actual medical practice.
Conditions
- Intestinal Amebiasis
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Pfizer CT.gov Call Center · Pfizer
Eligibility
- Min Age
- 15 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-10-19
- Primary Completion
- 2018-12-21
- Completion
- 2018-12-21
More Related Trials
-
Autoflor -Lyophilized Capsulated Autological FMT to Restore Gut Microbiome After Treatment With Antibiotics
NCT06250413 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Eradication of Antibiotic-resistant Bacteria Through Antibiotics and Fecal Bacteriotherapy
NCT02472600 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy of AEMCOLO (Rifamycin SV MMX) in the Treatment of Small Intestinal Bacterial Overgrowth (SIBO)
NCT04501380 ·Status: UNKNOWN ·Phase: PHASE2
-
Safety and Efficacy of Lyophilized Fecal Microbiota Transplantation Via Capsules for Intestinal Multidrug-resistant Bacteria Decolonization
NCT07106580 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Autologous Fecal Microbiota Transplantation (Auto-FMT) for Prophylaxis of Clostridium Difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation
NCT02269150 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Gut Microbiota Changes After Fecal Microbiota Transplantation
NCT02557685 ·Status: UNKNOWN ·Phase: PHASE2
-
Paromomycin or Metronidazole for Symptomatic Dientamoeba Fragilis in Adults
NCT06907498 ·Status: RECRUITING ·Phase: NA
-
Pharmaco-Scintigraphic Study to Evaluate the Release Profile of Metronidazole Benzoate Capsules
NCT02911298 ·Status: COMPLETED ·Phase: PHASE1
-
Pilot Study Using Oral Capsule FMT to Decolonize GI CRE
NCT03527056 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Autologous Fecal Microbiota Transplantation to Prevent Antibiotic Resistant Bacteria Colonization
NCT03061097 ·Status: COMPLETED ·Phase: PHASE1
-
Antibiotic Treatment Trial for Small Intestinal Bacterial Overgrowth
NCT02458781 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study To Assess The Safety, Tolerability And Pharmacokinetics Of Metronidazole Injection In Healthy Japanese Subjects
NCT01407016 ·Status: COMPLETED ·Phase: PHASE1
-
Mucosal Versus Fecal Microbiota in FMT
NCT02133651 ·Status: COMPLETED
-
Feasibility of a New Diagnostic Device to Assess Small Intestinal Dysbiosis in Routine Clinical Setting.
NCT04910815 ·Status: RECRUITING ·Phase: NA
-
The Clostridioides Difficile Trial of REC-3964
NCT06536465 ·Status: TERMINATED ·Phase: PHASE2
-
Developing Rectal USPE Measures
NCT02102867 ·Status: COMPLETED ·Phase: NA
-
Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection
NCT02589847 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 3 Study Of Intravenous Metronidazole For Intrabdominal Infection
NCT01473836 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C.Difficile - Associated Diarrhea
NCT00106509 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess the Levels of CAZ-AVI and Metronidazole in the Blood When Given Together and Separately
NCT01534247 ·Status: COMPLETED ·Phase: PHASE1
-
Fecal Transplantation in Patients Colonic Diverticulitis
NCT06254625 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Trial of Antimicrobials Versus Placebo in Addition to Fecal Transplant Therapy in Ulcerative Colitis
NCT02606032 ·Status: COMPLETED ·Phase: PHASE2
-
Placebo Controlled Study of Fecal Microbiota Transplant (FMT) for a First or Second Episode of C. Difficile Infection in Adults Using a Frozen Encapsulated Inoculum
NCT02343328 ·Status: TERMINATED ·Phase: PHASE1
-
The Role of the Gut Microbiota in the Systemic Immune Response During Human Endotoxemia
NCT02127749 ·Status: COMPLETED ·Phase: NA
-
Fecal Microbiome Transplant
NCT02636517 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1